期刊文献+

2010年多重耐药菌医院感染的分布及耐药性监测 被引量:23

Multidrug-resistant bacteria distribution and drug resistance monitoring of hospital infection in 2010
在线阅读 下载PDF
导出
摘要 目的回顾性分析2010年我院临床分离多重耐药菌(multidrug-resistant organism,MDRO)的分布及耐药性,为临床控制MDRO医院感染提供有效依据。方法采用全自动微生物分析仪VITEK-2进行细菌鉴定,K-B纸片扩散法进行药敏试验。采用WHONTE 5.4软件分析分离菌的分布、分离率及药敏结果。结果 3 737株分离菌中有2 255株为MDRO(60.3%),主要多重耐药菌为耐甲氧西林的金黄色葡萄球菌(MRSA)和凝固酶阴性的葡萄球菌(MRCNS)、产超广谱β-内酰胺酶(ESBLs)的大肠埃希菌(E.coli)和克雷伯菌(KNP)以及碳青霉烯耐药不动杆菌(CRABA)和铜绿假单胞菌(CRPAE)。革兰阳性MDRO仅对万古霉素和米诺环素比较敏感,MRSA对抗生素的耐药性较MRCNS更加严重,两者对环丙沙星、庆大霉素、克林霉素、米诺环素和左旋氧氟沙星的耐药率比较,差异有统计学意义(P<0.05),革兰阴性肠杆菌科细菌对亚胺培南、阿米卡星、头孢西丁和β-内酰胺/β-内酰胺酶抑制剂类抗生素敏感,革兰阴性非发酵菌对多黏菌素和头孢哌酮-舒巴坦较感。结论细菌的多重耐药性在临床分离菌株中非常普遍,对临床抗感染治疗构成了严重的威胁。合理选用抗菌药,及早检测MDRO,加强院内感染监测和采取有效的感染控制措施是控制感染播散的可行方法。 Objective To retrospectively study on the distribution of clinical isolates multidrug-resistant organism(MDRO) and drug resistance in 2010,in order to provide an effective basis for clinical control of MDRO in nosocomial infection.Methods Identification of bacteria was performed by automated microbe analyzer(VITEK-2) and antibiotic sensitivity test adopted Kirby-Bauer method.Date of isolation rate,drug resistant and sample distribution of bacteria were analyzed by WHONET 5.4 software.Results There were 2 255 strains were MDRO in the 3 737 isolates(60.3%),the main multi-drug resistant bacteria were Methicillin resistant strains in S.aureus(MRSA) and Coagulase negative staphylococcus(MRCNS),Production extra-broad spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae carbapenemase resistance Acinetobacter baumannii and pseudomonas aeruginaosa.Gram-positive.MDRO were sensitive to vancomycin and minocycline,Gram negative Enterobacteriaceae bacteria have high sensitive to imipenem,Amikacin,cefoxitin and beta-lactam/beta-lactamase inhibitor class of antibiotic,Gram-negative non-fermentative bacteria were sensitive only to colistin and cefoperazone/sulbactam.Conclusion Bacterial multiple antibiotic resistance in clinical strains is very popular,which has become a major challenge to clinical anti-infection treatment.Rational use of antibacterial drugs,early detection of MDRO,strengthen the surveillance of nosocomial infections and take effective infection control measures to control the spread is a feasible method.
出处 《中国医药导报》 CAS 2012年第6期84-86,93,共4页 China Medical Herald
关键词 多重耐药菌 医院感染 耐药性监测 标本分布 Multidrug-resistant organism Nosocomial infections Bacterial resistance surveillance Sample distribution
  • 相关文献

参考文献10

  • 1中华人民共和国卫生部.多重耐药菌医院感染预防与控制技术指南(试行)[S].2010.
  • 2俞汝佳,吕晓菊,高燕渝,杨仁国,徐开菊.鲍曼不动杆菌对米诺环素等抗菌药物的耐药性研究[J].中国抗生素杂志,2011,36(1):70-73. 被引量:35
  • 3Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing,Twenty-First information alsupplement[S].PA:Clinical and Laboratory Standards Institute,2010,31(1):161-163.
  • 4Kumarasamy KK,Toleman MA,Walsh TR,et al.Emergence of anew antibiotic resistance mechanism in India,Pakistan and the UK:a molecular,biological,and epidemiological study[J].Laneet Infect Dis,2010,10(9):597-602.
  • 5Lim D,Strynadka NC.Struetural basis for the beta laetma resistnaee of PBP2a from mehticillin-rersistnat stapahyloeoecus auareus[J].Nat Srtuet Biol,2002,9(11):870-876.
  • 6汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,李丽,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2010,10(5):325-334. 被引量:397
  • 7马君玲,马玲,马唯一.2006~2008年耐药菌株变迁分析[J].新疆医科大学学报,2009,32(9):1273-1275. 被引量:8
  • 8张晓兵,刘星,龚雅利,府伟灵.碳青霉烯类耐药鲍曼不动杆菌分子流行病学及耐药机制的研究[J].第三军医大学学报,2011,33(5):502-505. 被引量:18
  • 9Paul G.Higgins,Hilmar Wisplinghoff,Danuta Stefanik,et al.In vitro activities of the β-Lactamase inhibitors clavulanic acid,sulbactam,and tazobactam alone or in combination with β-Lactams against epidemiologically characterized multidrug-resistant acinetobacter baumannii strains[J].Antimicrobial Agents Aad Chemotherapy,2004,48(5):1586-1592.
  • 10杨春霞,王清涛,栗方,黎斌斌,杜小玲,肖白.北京地区五家医院获得性铜绿假单胞菌对碳青霉烯类抗菌药物耐药机制研究[J].中华检验医学杂志,2009,32(5):538-542. 被引量:12

二级参考文献42

共引文献459

同被引文献157

  • 1朱德妹,胡付品,汪复,蒋晓飞,俞云松,杨青,孙自镛,简翠,王传清,王爱敏,张泓,李万华,徐英春,孙宏莉,倪语星,孙景勇,徐元宏,沈继录,胡云建,艾效曼,单斌,杜艳,魏莲花,吴玲,苏丹虹,卓超,贾蓓,黄文祥,张朝霞,季萍.2009年中国CHINET葡萄球菌属细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):414-420. 被引量:60
  • 2邓伟明,谭国群.我院2005年住院患者不合理应用抗生素分析[J].河北医药,2006,28(5):423-424. 被引量:6
  • 3陈红梅.合理使用抗生素预防和控制医院感染[J].中华医院感染学杂志,2006,16(7):765-765. 被引量:8
  • 4曹艳菊,张豫生,许连壮,米晓森,王惠.微生态制剂对抗生素相关性腹泻预防作用的研究[J].中华医院感染学杂志,2007,17(1):17-19. 被引量:44
  • 5罗少锋,彭少华,顾剑.湖北地区金黄色葡萄球菌耐药性变迁[J].中华医院感染学杂志,2007,17(8):996-997. 被引量:14
  • 6Rosenthal VD,Maki DG,Graves N.The International Noso-comial Infection Control Consortium(INICC):goals and ob-jectives,description of surveillance methods,and operationalactivities[J].Am J Infect Control,2008,36(9):e1-e12.
  • 7Tumbarello M,Spanu T,Sanguinetti M,et al. Blot:dstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors,molecular epidemiology,and clinical outcome [J]. Antimierob Agents Chemother, 2006,50 (2) : 498-504.
  • 8Rahal JJ. The role of carbapenems in initial therapy for serious Gram-negative infections [J]. Crit Care, 2008,12, ($4): 5.
  • 9Zhang R,Zhou HW,Cai JC,et al. Plasmid-mediated carbapenem- hydrolysing beta-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou,China [J]. j Antimicrob Chemother, 2007,59 (3) : 574-576.
  • 10Cai JC,Zhou HW,Zhang R,et al. Emergence of Serratia marcescens, Klebsiella pneumoniae,and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital [J]. Antimicrob Agents Chemother, 2008,52 (6) : 2014-2018.

引证文献23

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部